Dr. Elena Grigorenko has over 15 years experience across R&D and product development in the pharmaceutical and biotechnical industries and has participated in several successful commercial product launches.
Prior to joining Diatherix Eurofins, as Director and later Vice-President of Research and Development in February 2013, she served as Associate Director at Life Technologies, Inc where her responsibilities included leadership of high-throughput PCR application team, scientific and business development programs and establishing collaborative studies in the area of genomics with leading academic, government and industrial researchers. She also played a major role in securing 3 years research contract with Food and Drug Administration on development of multiplex PCR panels for detection of blood-borne pathogens.
Previously, Elena served at roles of increased responsibilities at Caliper Life Sciences, Perkin Elmer, Inc and Millennium Pharmaceuticals, Inc. She was also a member of Scientific Advisory Board of Nugen Technologies, Inc from 2000-2003. She is author of more than 30 peer-reviewed publications and three patent applications. Dr. Grigorenko graduated with Honors from Saratov State University (USSR) and received her PhD in Biochemistry from Institute of Biological Physics of Russian Academy of Sciences.